Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

SR 412Session 2025-2026

A Resolution directing the Legislative Budget and Finance Committee to conduct a performance audit of pharmacy benefit arrangements under the Commonwealth's Medical Assistance managed care program, including the use of public resources, payment transparency, applicable requirements, Department of Human Services oversight and beneficiary pharmacy access and report its findings and recommendations.

Printer's No. PN2084

See other bills
under the
same topic PRINTER'S NO. 2084 THE GENERAL ASSEMBLY OF PENNSYLVANIASENATE RESOLUTION No.412 Session of 2026 INTRODUCED BY TARTAGLIONE AND J. WARD, OCTOBER 27, 2026 REFERRED TO HEALTH AND HUMAN SERVICES, OCTOBER 27, 2026 A RESOLUTIONDirecting the Legislative Budget and Finance Committee to conduct a performance audit of pharmacy benefit arrangements under the Commonwealth's Medical Assistance managed care program, including the use of public resources, payment transparency, applicable requirements, Department of Human Services oversight and beneficiary pharmacy access and report its findings and recommendations.WHEREAS, Pharmacists and other stakeholders have expressed concerns about pharmacy reimbursement, fees, network participation and beneficiary access under Medical Assistance managed care and the extent and contributing factors of those concerns warrant independent examination; andWHEREAS, Medical Assistance managed care pharmacy arrangements involve the Department of Human Services, managed care organizations (MCOs), pharmacy benefit managers (PBMs), and pharmacies and transparent payment information and effective oversight are important to accountability for public resources and access to covered services; andWHEREAS, Act 77 of 2024 addressed pharmacy benefit practices and required the Insurance Department to study specified issues in the fully insured commercial insurance market; and123456789101112131415161718192021 WHEREAS, The Insurance Department's May 2026 study excluded Medicaid and does not establish the payment practices, access conditions or policy effects in Medical Assistance managed care; andWHEREAS, An independent examination can inform legislative decisions regarding pharmacy reimbursement, network protections, purchasing arrangements, reporting requirements and oversight; therefore be itRESOLVED, That the Senate direct the Legislative Budget and Finance Committee to conduct a performance audit of pharmacy benefit arrangements under the Commonwealth's Medical Assistance managed care program, including the use of public resources, payment transparency, applicable requirements, Department of Human Services oversight and beneficiary pharmacy access and report its findings and recommendations; and be it furtherRESOLVED, That the principal payment analysis cover the most recent complete 12-month service period ending before adoption of this resolution for which sufficient claims run out and reconciled payment information can be obtained, with the period and covered managed care arrangements documented by the committee within 30 calendar days after adoption of this resolution and that limited records outside that period may be examined as necessary to understand contract history, network changes and implementation of oversight actions; and be it furtherRESOLVED, That the audit:(1) describe Medicaid managed care pharmacy utilization and payment patterns and compare selected, sufficiently comparable measures with the Insurance Department's fully insured commercial study, identifying differences in 20260SR0412PN2084 - 2 - 123456789101112131415161718192021222324252627282930 populations, periods, benefits, methods and data coverage;(2) examine PBM payments to pharmacies, including ingredient reimbursement, dispensing fees, transaction fees and other adjustments and evaluate selected practices against applicable Medicaid law and executed contracts;(3) examine MCO payments to PBMs, separately identifying pharmacy service reimbursement and administrative compensation and reconcile these amounts, to the extent supported by reliable records, with pharmacy payments and relevant fees, credits and rebates;(4) compare ingredient reimbursement, dispensing fees and total net reimbursement for independent and chain pharmacies, separately classifying PBM affiliation and dispensing channel and accounting, where practicable, for differences in drug and prescription characteristics;(5) review selected other states' Medicaid pharmacy oversight and purchasing approaches, including at least one single-PBM approach and assess documented results, evidence limitations and considerations for potential application in Pennsylvania;(6) evaluate Department of Human Services oversight and selected practices involving steering, pharmacy network restrictions and payment differentials, including potential spread pricing, against applicable requirements, describe documented access and cost indicators and associations without attributing causation unless the evidence and design support it; and(7) estimate pharmacy reimbursement differences under a scenario using applicable historical national average drug acquisition cost, or NADAC, unit prices plus a $10.49 20260SR0412PN2084 - 3 - 123456789101112131415161718192021222324252627282930 dispensing fee per prescription, which shall disclose coverage gaps, assumptions and sensitivity results and identify evidence needed to assess future access, utilization and public expenditures;and be it furtherRESOLVED, That the Department of Human Services be requested, using authority available under applicable law and executed contracts, to cooperate with the committee and coordinate the timely provision by the department, managed care organizations and pharmacy benefit managers of:(1) records reasonably necessary for the audit, including executed contracts and material amendments;(2) claims, remittance, billing and payment records;(3) ingredient reimbursement, dispensing fees, member cost share and third-party liability;(4) administrative, processing and transaction fees;(5) rebates, credits and other adjustments and their allocation methods;(6) pharmacy network and ownership information;(7) complaints and appeals;(8) contract approval, monitoring, audit and corrective-action records;(9) any other data the Legislative Budget and Finance Committee deems necessary to carry out the objectives of this resolution;and be it furtherRESOLVED, That the Insurance Department be requested to provide the department's existing commercial-market study data, definitions, methods and reasonably necessary supporting information to permit the limited comparison described in this 20260SR0412PN2084 - 4 - 123456789101112131415161718192021222324252627282930 resolution, subject to applicable law and the Legislative Budget and Finance Committee's assessment of comparability and reliability, and any other data the Legislative Budget and Finance Committee deems necessary to carry out the objectives of this resolution; and be it furtherRESOLVED, That the Department of Human Services, the Insurance Department and relevant managed care organizations and pharmacy benefit managers be requested to identify records custodians and coordinate specifications with the committee within 15 calendar days after adoption, provide representative sample extracts and documentation within 30 calendar days, deliver complete records and datasets to the committee within 60 calendar days and resolve material deficiencies identified by the committee by 90 calendar days after adoption; and be it furtherRESOLVED, That submissions include data dictionaries, extract specifications, record and payment control totals, coverage and exclusion information, reconciliation methods and stable analytic identifiers sufficient to link related claims and payments without unnecessary personal identifiers and any other data the Legislative Budget and Finance Committee deems necessary to carry out the objectives of this resolution; and be it furtherRESOLVED, That the Legislative Budget and Finance Committee use secure, legally permissible data-handling arrangements, preserve confidentiality and privilege to the extent provided by applicable law and use de-identified information or another legally authorized disclosure mechanism appropriate to the audit's necessary linkages and that public claims and financial results be presented in aggregate or redacted form as necessary 20260SR0412PN2084 - 5 - 123456789101112131415161718192021222324252627282930 to protect information from disclosure as required by law; and be it furtherRESOLVED, That the committee provide the Senate a feasibility and progress report within 90 calendar days after adoption identifying record availability and reliability, staffing and specialist needs, material impediments and whether the approved scope remains achievable and that the committee promptly seek appropriate legislative authorization for a material change in required coverage or the reporting deadline if necessary, without treating a progress report or delayed data receipt as extending that deadline.20260SR0412PN2084 - 6 - 1234567891011

Official text from the Pennsylvania Legislature. Formatting has been adapted for reading on Ratifi.